简介:
Overview
This article describes a protocol for rapid CRISPR/Cas9-mediated gene disruption in mouse and human primary hematopoietic cells using a ribonucleoprotein approach. The method allows for high editing efficiencies with minimal time and cost.
Key Study Components
Area of Science
- Gene editing
- Hematopoietic cell biology
- CRISPR/Cas9 technology
Background
- CRISPR/Cas9 is a powerful tool for gene disruption.
- Primary hematopoietic cells are crucial for studying hematopoiesis.
- Traditional delivery methods for CRISPR can be toxic or slow.
- This protocol aims to improve efficiency and reduce costs.
Purpose of Study
- To develop a fast and efficient method for gene disruption.
- To investigate the effects of gene loss in hematopoietic progenitor cells.
- To provide a protocol applicable to various cell types.
Methods Used
- Designing single-guide RNAs using CRISPRscan.
- Synthesizing RNA and preparing Cas9-sgRNA ribonucleoprotein complexes.
- Electroporating primary hematopoietic cells with the RNP complexes.
- Assessing gene disruption efficiency using flow cytometry and T7 endonuclease assays.
Main Results
- Achieved approximately 75% loss of target gene expression in HSPCs.
- Demonstrated 98% knockout efficiency in HL-60 AML cell line.
- Showed effective gene disruption in primary human cord blood cells.
- Confirmed engraftment of edited cells in NSG mice.
Conclusions
- The protocol is efficient and can be completed in under a week.
- It is applicable to various hematopoietic cell types.
- Maintaining RNase-free conditions is critical for success.
What is the main advantage of this CRISPR method?
It is easy, fast, and cost-effective, allowing for rapid gene disruption.
Can this method be used for other cell types?
Yes, it can be applied to primary T-cells and various hematopoietic cell lines.
How long does the protocol take to complete?
The entire process can be completed in less than a week.
What techniques are used to verify gene disruption?
Flow cytometry and T7 endonuclease assays are used to assess gene editing efficiency.
What precautions should be taken during the protocol?
All surfaces and reagents must be kept RNase-free to ensure successful results.